hematological malignacies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with hematologic malignancies, including leukemia, lymphoma, multiple myeloma, and myelodysplastic syndrome, who meet the diagnostic criteria of the International Classification of Diseases (ICD-10); 2. At least 1 month or more of chemical treatment; 3. Age =18 years old, male or female; 4. Fear of Disease Progression Scale (FOP-Q-SF) =34 points; 5. The patient is expected to survive for more than 3 months; 6. The patient knows the condition; 7. The patient himself or under the guidance of family members skilled use of smart phones; 8. Voluntarily participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Previous psychiatric history, severe cognitive impairment and mental illness; 2. Severe visual, auditory, and language impairment; 3. Accompanied by serious physical disease or other tumors; 4. The patient is in critical condition and cannot cooperate with the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fear of disease progression; | — |
Secondary
| Measure | Time frame |
|---|---|
| resilience;quality of life; | — |
Countries
China
Contacts
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College